COM_RESEARCHSTUDIES_DETAIL_AVAL_STATUS_4

Randomized, double-blind, phase III clinical trial of neoadjuvant chemotherapy or a placebo in patients with triple-negative breast cancer followed by adjubant chemotherapy or a placebo

To determine if the usual chemotherapy given before surgery for breast cancer plus an experimental drug is better than the usual chemotherapy plus a placebo.

Age & Gender

18 years ~ 99 years
Male, Female

Contact the Team

Location

COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4

North Carolina (Edgecombe, Nash)

Additional Study Information

Principal Investigator

Elie Choufani
UNC Hospitals - Nash

Study Topics

Aging
Cancer (Breast)
Surgery and post-operative healing
Women's Health
Men's Health

IRB Number

19-1760

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.